AbridgeTranslation site

What's Abridge?

Abridge is an American medical artificial intelligence company founded in 2018 and headquartered in Pittsburgh, Pennsylvania. Co-founded by Shivdev Rao, M.D., Florian Metze, Ph.D., and Sandeep Konam, the company is focused on developing apps that utilize artificial intelligence technology to record and summarize medical conversations. Its core product converts patient-physician conversations into structured clinical notes in real-time and seamlessly integrates with electronic medical record (EMR) systems.

The company has raised more than $212 million through multiple rounds of funding, including a $150 million Series C round co-led by Lightspeed Venture Partners and Redpoint Ventures.2025 In February, Abridge announced the closing of a $250 million Series D financing round, valuing the company at $2.5 billion dollars. Its products have access to more than 100 health systems across the U.S., and its customers include well-known organizations such as Duke Health and Mayo Clinic.

Abridge's core business

• Products & Services: Abridge's core product is an AI-based medical conversation recording tool that transforms doctor-patient conversations into structured clinical notes in real time and synchronizes them directly to electronic medical record (EMR) systems. The technology accurately extracts key medical information (e.g., diagnosis, medication recommendations, etc.) through natural language processing and machine learning algorithms, helping doctors reduce time-consuming paperwork and improve diagnosis and treatment efficiency.
• Technical characteristics: Abridge's AI technology utilizes data extracted from over 1.5 million medical conversations to improve the speed and accuracy of medical records. Its platform supports 28 languages and has access to more than 100 health systems across the U.S., with clients including Duke Health, Mayo Clinic, and other well-known organizations.

Abridge's market performance and competitiveness

• market position: Abridge tops the Forbes AI 50 list in 2024 with its technological breakthroughs and commercial landing ability, becoming a benchmark company in the healthcare AI field.
• Competitive advantages: Abridge's competitive advantage lies in the innovative nature of its technology and its focus on the practicality of improving the recording of medical conversations, as well as its strong R&D team and close collaboration with clinicians. In addition, Abridge focuses on data privacy compliance, system compatibility and clinical scenario adaptation to meet the specific needs of the healthcare industry.

Abridge's Business Model and Partners

• business model: Abridge generates revenue by providing subscription services to health systems, and the company expects its ARR (annual recurring revenue) to reach $50 million in 2024.
• cooperative partner: Abridge has established partnerships with technology companies such as NVIDIA to leverage their computing resources and expertise to expand their artificial intelligence systems. In addition, Abridge has established partnerships with several healthcare organizations and insurance companies to drive widespread adoption of its products.